Enhanced photodynamic effects using fractionated laser light.

Photodynamic eradication of tumour cells depends on the presence of a photosensitizer and light delivery to the cells. The present study investigated the influence of fractionated light (on-off mode) on cell killing as documented by a colony-forming assay. Photosensitizers were m-THPC (ethanol soluble, Foscan) and m-THPC-MD (water soluble, both from Scotia Pharmaceuticals, Guildford, UK). Fractionated laser light at a wavelength of 652 nm with a light duration of 0.05 s was more effective than continuous illumination at the same power density for both photosensitizers. We propose that fractionated laser light is more toxic due to short phases of recovery during the dark intervals, probably resulting in more singlet oxygen under these conditions. By use of Foscan, for example, and fractionated laser light, a similar effect is expected for the treatment of solid tumours. In this case we expect improvements in photodynamic therapy (PDT) for patients by lowering the concentrations of photosensitizer and/or by reducing the applied light dose.

[1]  J Moan,et al.  RETENTION AND PHOTOTOXICITY OF TETRA(4‐SULFONATOPHENYL)PORPHINE IN CULTIVATED HUMAN CELLS. THE EFFECT OF FRACTIONATION OF LIGHT , 1992, Photochemistry and photobiology.

[2]  N. Crompton,et al.  In vitro effects and localisation of the photosensitizers m‐THPC and m‐THPC MD on carcinoma cells of the human breast (MCF‐7) and chinese hamster fibroblasts (V‐79) , 1997, Lasers in surgery and medicine.

[3]  H. Bergh,et al.  Preliminary clinical results on a second generation photosensitizer: mTHPC , 1992 .

[4]  M C Berenbaum,et al.  meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. , 1986, British Journal of Cancer.

[5]  C. Richter,et al.  Photosensitization of isolated rat liver mitochondria by tetra(m-hydroxyphenyl)chlorin. , 1997, Archives of biochemistry and biophysics.

[6]  S. Bhardwaj.  New approaches to cancer treatment. , 1991, Comprehensive therapy.

[7]  F. S. Ambesi-Impiombato,et al.  Effects of laser irradiation on hematoporphyrin-treated normal and transformed thyroid cells in culture. , 1983, Cancer research.

[8]  J Moan,et al.  Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers , 1994, International journal of cancer.

[9]  Kevin M. Smith,et al.  CHLORIN AND PORPHYRIN DERIVATIVES AS POTENTIAL PHOTOSENSITIZERS IN PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.

[10]  D. A. Russell,et al.  OCTA‐ALKYL ZINC PHTHALOCYANINES: POTENTIAL PHOTOSENSITIZERS FOR USE IN THE PHOTODYNAMIC THERAPY OF CANCER , 1995, Photochemistry and photobiology.

[11]  D B Plewes,et al.  Mammographic scanning equalization radiography. , 1993, Medical physics.

[12]  J. Spikes.  PHTHALOCYANINES AS PHOTOSENSITIZERS IN BIOLOGICAL SYSTEMS AND FOR THE PHOTODYNAMIC THERAPY OF TUMORS , 1986, Photochemistry and photobiology.

[13]  P A Cowled,et al.  COMPARISON OF THE EFFICACY OF PULSED AND CONTINUOUS‐WAVE RED LASER LIGHT IN INDUCTION OF PHOTOCYTOTOXICITY BY HAEMATOPORPHYRIN DERIVATIVE , 1984, Photochemistry and photobiology.

[14]  C. Gomer,et al.  PHOTOINACTIVATION OF CHINESE HAMSTER CELLS BY HEMATOPORPHYRIN DERIVATIVE AND RED LIGHT , 1980, Photochemistry and photobiology.

[15]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[16]  T. Dougherty,et al.  MEMBRANE LYSIS IN CHINESE HAMSTER OVARY CELLS TREATED WITH HEMATOPORPHYRIN DERIVATIVE PLUS LIGHT , 1982, Photochemistry and photobiology.

[17]  Rick E. Sneed,et al.  Comparative study between pulsed and continuous wave lasers for Photofrin® photodynamic therapy , 1993, Lasers in surgery and medicine.

[18]  J. Spikes.  Chlorins as photosensitizers in biology and medicine. , 1990 .

[19]  M C Berenbaum,et al.  Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. , 1989, The Biochemical journal.

[20]  R. Boyle,et al.  Structure and Biodistribution Relationships of Photodynamic Sensitizers * , 1996, Photochemistry and photobiology.

[21]  D. Kessel,et al.  HEMATOPORPHYRIN and HPD: PHOTOPHYSICS, PHOTOCHEMISTRY and PHOTOTHERAPY , 1984, Photochemistry and photobiology.

[22]  W. Star,et al.  PILOT STUDY ON LIGHT DOSIMETRY FOR ENDOBRONCHIAL PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.

[23]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[24]  G. Jori,et al.  Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis. , 1990, British Journal of Cancer.

[25]  T. Hasan,et al.  A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. , 1997, Radiation research.